Tao Wu1, Chaodong Wang, Jue Wang, Mark Hallett, Yufeng Zang, Piu Chan. 1. Department of Neurobiology, Key Laboratory on Neurodegenerative Disorders of Ministry of Education, Beijing Institute of Geriatrics, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Abstract
BACKGROUND: The pathophysiological changes before the presentation of clinical symptoms in parkinsonism are unclear. In this study, we investigated neural network modulations in persons in the preclinical stage of familial parkinsonism, and how the network interactions change at the clinical stage. METHODS: We performed functional MRI in a family with SCA2 mutation, including 9 asymptomatic carriers and 10 mutation carriers with parkinsonian symptoms. Functional connectivity from the posterior putamen bilaterally and rostral supplementary motor area was used to explore network interactions in the subjects. RESULTS: Both the asymptomatic carriers and patients had decreased connectivity within the basal ganglia-thalamus-cortical motor loop compared to controls. The asymptomatic carriers showed extensively increased connectivity compared to controls, including the cortico-cortical motor, cortico-cerebellar, cortico-brainstem, and part of the basal ganglia-thalamus-cortical motor circuits. In contrast, the connectivity of most of these networks was decreased in the patients. These abnormalities were relatively normalized after levodopa administration. CONCLUSIONS: In the preclinical stage of SCA2 parkinsonism, the connectivity of a part of the basal ganglia motor loop is weakened as a consequence of dopaminergic deficits; meanwhile, the connectivity of other large-scale brain networks is strengthened presumably to compensate for the dysfunction of the basal ganglia to maintain brain function in the early stage of dopaminergic deficits. The simultaneous effects of progressive disruption of basal ganglia motor circuits and failure of compensatory mechanisms as dopaminergic dysfunction progresses may contribute to the onset of clinical symptoms.
BACKGROUND: The pathophysiological changes before the presentation of clinical symptoms in parkinsonism are unclear. In this study, we investigated neural network modulations in persons in the preclinical stage of familial parkinsonism, and how the network interactions change at the clinical stage. METHODS: We performed functional MRI in a family with SCA2 mutation, including 9 asymptomatic carriers and 10 mutation carriers with parkinsonian symptoms. Functional connectivity from the posterior putamen bilaterally and rostral supplementary motor area was used to explore network interactions in the subjects. RESULTS: Both the asymptomatic carriers and patients had decreased connectivity within the basal ganglia-thalamus-cortical motor loop compared to controls. The asymptomatic carriers showed extensively increased connectivity compared to controls, including the cortico-cortical motor, cortico-cerebellar, cortico-brainstem, and part of the basal ganglia-thalamus-cortical motor circuits. In contrast, the connectivity of most of these networks was decreased in the patients. These abnormalities were relatively normalized after levodopa administration. CONCLUSIONS: In the preclinical stage of SCA2 parkinsonism, the connectivity of a part of the basal ganglia motor loop is weakened as a consequence of dopaminergic deficits; meanwhile, the connectivity of other large-scale brain networks is strengthened presumably to compensate for the dysfunction of the basal ganglia to maintain brain function in the early stage of dopaminergic deficits. The simultaneous effects of progressive disruption of basal ganglia motor circuits and failure of compensatory mechanisms as dopaminergic dysfunction progresses may contribute to the onset of clinical symptoms.
Authors: Thilo van Eimeren; Ferdinand Binkofski; Carsten Buhmann; Johann Hagenah; Antonio P Strafella; Peter P Pramstaller; Hartwig R Siebner; Christine Klein Journal: Parkinsonism Relat Disord Date: 2010-07 Impact factor: 4.891
Authors: K Gwinn-Hardy; J Y Chen; H C Liu; T Y Liu; M Boss; W Seltzer; A Adam; A Singleton; W Koroshetz; C Waters; J Hardy; M Farrer Journal: Neurology Date: 2000-09-26 Impact factor: 9.910
Authors: B F L van Nuenen; M M Weiss; B R Bloem; K Reetz; T van Eimeren; K Lohmann; J Hagenah; P P Pramstaller; F Binkofski; C Klein; H R Siebner Journal: Neurology Date: 2008-11-26 Impact factor: 9.910
Authors: Jamie Purzner; Guillermo O Paradiso; Danny Cunic; Jean A Saint-Cyr; Tasnuva Hoque; Andres M Lozano; Anthony E Lang; Elena Moro; Mojgan Hodaie; Filomena Mazzella; Robert Chen Journal: J Neurosci Date: 2007-05-30 Impact factor: 6.167
Authors: Michela Pievani; Nicola Filippini; Martijn P van den Heuvel; Stefano F Cappa; Giovanni B Frisoni Journal: Nat Rev Neurol Date: 2014-10-07 Impact factor: 42.937
Authors: Fabrizio De Vico Fallani; Silvia Clausi; Maria Leggio; Mario Chavez; Miguel Valencia; Anton Giulio Maglione; Fabio Babiloni; Febo Cincotti; Donatella Mattia; Marco Molinari Journal: Cerebellum Date: 2017-04 Impact factor: 3.847
Authors: José Luiz Pedroso; Pedro Braga-Neto; Marcio Luiz Escorcio-Bezerra; Agessandro Abrahão; Marcus Vinicius Cristino de Albuquerque; Flavio Moura Rezende Filho; Paulo Victor Sgobbi de Souza; Wladimir Bocca Vieira de Rezende Pinto; Franklin Roberto Pereira Borges; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim; Orlando G P Barsottini Journal: Cerebellum Date: 2017-02 Impact factor: 3.847